Polynucleotide detection by isothermal amplification using cleavable oligonucleotides

• US 5,747,255 A
• Filed: 09/29/1995
• Issued: 05/05/1998
• Est. Priority Date: 09/29/1995
• Status: Expired due to Term

• Current Assignee: Lynx Therapeutics, Inc. (Illumina Incorporated)
• Original Assignee: Lynx Therapeutics, Inc. (Illumina Incorporated)
• Inventors: Brenner, Sydney
• Primary Examiner(s): ARTHUR, LISA BENNETT
• Application Number:
  US08/536,743
• Time in Patent Office: 949 Days
• Field of Search: 435/6, 435/91.2, 435/91.21, 935/77, 935/78
• US Class Current: 435/6.1
• CPC Class Codes: C12Q 1/682 Signal amplification
• CPC Class Codes: C12Q 1/6823 Release of bound markers
• CPC Class Codes: C12Q 2521/307 Single strand endonuclease
• CPC Class Codes: C12Q 2525/121 incorporating both deoxyribonucleotides and ribonucleotides
• CPC Class Codes: C12Q 2537/157 A reaction step characterised by the number of molecules incorporated or released
• CPC Class Codes: C12Q 2563/107 fluorescence
• CPC Class Codes: C12Q 2563/143 Magnetism, e.g. magnetic label

Abstract

A method for detecting a target polynucleotide is provided which relies on the exponential amplification of oligonucleotide fragments. Separated populations of oligonucleotides are provided that contain complementary sequences to one another and that contain at least one scissile linkage which is cleaved whenever a perfectly matched duplex is formed containing the linkage. When a target polynucleotide contacts a first oligonucleotide cleavage occurs and a first fragment is produced which can hybridize with a second oligonucleotide. Upon such hybridization, the second oligonucleotide is cleaved releasing a second fragment that can, in turn, hybridize with a first oligonucleotide in a manner similar to that of the target polynucleotide. Upon such hybridization, cleavage again occurs and an additional first fragment is produced which can hybridize

Claims

1. A method of detecting a target polynucleotide, the method comprising the steps of:

(a) providing a first oligonucleotide having

(i) a nucleotide sequence complementary to a portion of a target polynucleotide and

(ii) a scissile linkage within said portion which is cleavable by a selected cleaving agent whenever the first oligonucleotide forms a perfectly matched duplex with said portion such that a first fragment is released from the first oligonucleotide, the first fragment having a nucleotide sequence complementary to said portion of the target polynucleotide;

(b) providing a second oligonucleotide having

(i) a nucleotide sequence identical to that of said portion of the target polynucleotide and

(ii) a scissile linkage within said portion which is cleavable by a selected cleaving agent which may be the same as or different from said first cleaving agent whenever the second oligonucleotide forms a perfectly matched duplex with the first fragment such that a second fragment is released from the second oligonucleotide, the second fragment having a nucleotide sequence complementary to said portion of the first oligonucleotide;

(c) maintaining the first oligonucleotide and the second oligonucleotide in substantial physical separation such that the formation of perfectly matched duplexes between any first oligonucleotides and any second oligonucleotides is inhibited and such that released first fragments may diffusibly communicate with the second oligonucleotides and released second fragments may diffusibly communicate with the first oligonucleotides; and

(d) exposing the first and second oligonucleotides to the target polynucleotide in the presence of said cleaving agent(s) under conditions effective to cleave said scissile linkages when said duplexes are formed, and

(i) wherein duplexes between the first oligonucleotide and the portion of the target polynucleotide, duplexes between the first oligonucleotide and the second fragment, and duplexes between the second oligonucleotide and the first fragment are stable, and

(ii) wherein duplexes between cleaved first oligonucleotides and the second fragments and duplexes between cleaved second oligonucleotides and the first fragments are unstable, such that an increase in the concentrations of the first and second fragments is an indication of the presence of the target polynucleotide.

2. The method of claim 1 wherein said first oligonucleotides are attached to microparticles separate from said second oligonucleotides and wherein said second oligonucleotides are attached to microparticles separate from said first oligonucleotides.

3. The method of claim 2 wherein said scissile linkage of said first oligonucleotides comprises one or more segments of RNA and wherein said scissile linkage is cleaved by an RNase H activity of an enzyme.

4. The method of claim 3 wherein said scissile linkage of said second oligonucleotides comprises one or more segments of RNA and wherein said scissile linkage is cleaved by an RNase H activity of an enzyme.

5. The method of claim 4 wherein said first and said second oligonucleotides each have a single RNA segment between two and ten RNA monomers in length.

6. The method of claim 5 wherein said conditions for exposing said target polynucleotide to said first and second oligonucleotides are isothermal at a temperature in the range of 32°

C. to 60°

C.

7. The method of claim 2 wherein said scissile linkage of said first oligonucleotides comprises one or more restriction endonuclease cleavage sites each having a nuclease-resistant moiety on a single strand of said sites and wherein said scissile linkage is cleaved by a restriction endonuclease recognizing said site.

8. The method of claim 7 wherein said scissile linkage of said second oligonucleotides comprises one or more restriction endonuclease cleavage sites each having a nuclease-resistant moiety on a single strand of said sites and wherein said scissile linkage is cleaved by a restriction endonuclease recognizing said site.

9. The method of claim 8 wherein said first and said second oligonucleotides each have a single restriction endonuclease cleavage site.

10. The method of claim 9 wherein said conditions for exposing said target polynucleotide to said first and second oligonucleotides are isothermal at a temperature in the range of 32°

C. to 60°

C.